Author

Shivani Chandel

National Institute of Pharmaceutical Education and Research

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:mechanistic / dynamical model· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Anirban MannaiD· 1 shared HOSSAINOOR RAHAMAN SARENG· 1 shared Izaz Monir Kamal· 1 shared Jayanta MukhopadhyayiD· 1 shared Mahadeb PaliD· 1 shared Naibedya Dutta· 1 shared Nilanjana GhoshiD· 1 shared Rajiv Kumar Goswami· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

Anirban MannaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Epoxyazadiradione ameliorates Parkinson's disease by upregulating heat shock factor 1 and protein degradation pathways in mice.

Shivani Chandel, Naibedya Dutta, HOSSAINOOR RAHAMAN SARENG, Nilanjana Ghosh, Izaz Monir Kamal, Anirban Manna, V. Ravichandiran, Jayanta Mukhopadhyay, Saikat Chkrabarti, Rajiv Kumar Goswami, Mahadeb Pal

This paper identifies Epoxyazadiradione as a compound that improves Parkinson's disease symptoms in mice by enhancing heat shock factor 1 and protein degradation pathways without affecting redox balance.

bioRxiv · Dec 11, 2025 · PreprintPharmacology & Toxicology